Hurst CD - Search Results

1

Spectrum of phosphatidylinositol 3-kinase pathway gene alterations in bladder cancer.

Platt FM, Hurst CD, Taylor CF, Gregory WM, Harnden P, Knowles MA. Platt FM, et al. Among authors: hurst cd. Clin Cancer Res. 2009 Oct 1;15(19):6008-17. doi: 10.1158/1078-0432.CCR-09-0898. Epub 2009 Sep 29. Clin Cancer Res. 2009. PMID: 19789314

2

High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization.

Hurst CD, Fiegler H, Carr P, Williams S, Carter NP, Knowles MA. Hurst CD, et al. Oncogene. 2004 Mar 18;23(12):2250-63. doi: 10.1038/sj.onc.1207260. Oncogene. 2004. PMID: 14968109

3

FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma.

Jebar AH, Hurst CD, Tomlinson DC, Johnston C, Taylor CF, Knowles MA. Jebar AH, et al. Among authors: hurst cd. Oncogene. 2005 Aug 4;24(33):5218-25. doi: 10.1038/sj.onc.1208705. Oncogene. 2005. PMID: 15897885

4

DBC1 re-expression alters the expression of multiple components of the plasminogen pathway.

Louhelainen JP, Hurst CD, Pitt E, Nishiyama H, Pickett HA, Knowles MA. Louhelainen JP, et al. Among authors: hurst cd. Oncogene. 2006 Apr 13;25(16):2409-19. doi: 10.1038/sj.onc.1209228. Oncogene. 2006. PMID: 16369496

5

Expression of hTERT immortalises normal human urothelial cells without inactivation of the p16/Rb pathway.

Chapman EJ, Hurst CD, Pitt E, Chambers P, Aveyard JS, Knowles MA. Chapman EJ, et al. Among authors: hurst cd. Oncogene. 2006 Aug 17;25(36):5037-45. doi: 10.1038/sj.onc.1209513. Epub 2006 Apr 17. Oncogene. 2006. PMID: 16619045

6

Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancer.

Tomlinson DC, Hurst CD, Knowles MA. Tomlinson DC, et al. Among authors: hurst cd. Oncogene. 2007 Aug 30;26(40):5889-99. doi: 10.1038/sj.onc.1210399. Epub 2007 Mar 26. Oncogene. 2007. PMID: 17384684 Free PMC article.

7

Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study.

Dyrskjøt L, Zieger K, Real FX, Malats N, Carrato A, Hurst C, Kotwal S, Knowles M, Malmström PU, de la Torre M, Wester K, Allory Y, Vordos D, Caillault A, Radvanyi F, Hein AM, Jensen JL, Jensen KM, Marcussen N, Orntoft TF. Dyrskjøt L, et al. Clin Cancer Res. 2007 Jun 15;13(12):3545-51. doi: 10.1158/1078-0432.CCR-06-2940. Clin Cancer Res. 2007. PMID: 17575217 Free article.

8

Disruption of the FA/BRCA pathway in bladder cancer.

Neveling K, Kalb R, Florl AR, Herterich S, Friedl R, Hoehn H, Hader C, Hartmann FH, Nanda I, Steinlein C, Schmid M, Tonnies H, Hurst CD, Knowles MA, Hanenberg H, Schulz WA, Schindler D. Neveling K, et al. Among authors: hurst cd. Cytogenet Genome Res. 2007;118(2-4):166-76. doi: 10.1159/000108297. Cytogenet Genome Res. 2007. PMID: 18000367

9

Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.

Hurst CD, Tomlinson DC, Williams SV, Platt FM, Knowles MA. Hurst CD, et al. Oncogene. 2008 Apr 24;27(19):2716-27. doi: 10.1038/sj.onc.1210934. Epub 2007 Nov 26. Oncogene. 2008. PMID: 18037967 Free PMC article.

10

Papillary and muscle invasive bladder tumors with distinct genomic stability profiles have different DNA repair fidelity and KU DNA-binding activities.

Bentley J, L'Hôte C, Platt F, Hurst CD, Lowery J, Taylor C, Sak SC, Harnden P, Knowles MA, Kiltie AE. Bentley J, et al. Among authors: hurst cd. Genes Chromosomes Cancer. 2009 Apr;48(4):310-21. doi: 10.1002/gcc.20641. Genes Chromosomes Cancer. 2009. PMID: 19105236

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters